DK1276470T3 - Smagskaskerende overtrækssammensætning - Google Patents

Smagskaskerende overtrækssammensætning

Info

Publication number
DK1276470T3
DK1276470T3 DK01930585T DK01930585T DK1276470T3 DK 1276470 T3 DK1276470 T3 DK 1276470T3 DK 01930585 T DK01930585 T DK 01930585T DK 01930585 T DK01930585 T DK 01930585T DK 1276470 T3 DK1276470 T3 DK 1276470T3
Authority
DK
Denmark
Prior art keywords
coating composition
flavor
crushing coating
crushing
masks
Prior art date
Application number
DK01930585T
Other languages
Danish (da)
English (en)
Inventor
Jatin Desai
Ronald Warrick
Michael Corbo
Mahesh Patell
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1276470T3 publication Critical patent/DK1276470T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
DK01930585T 2000-04-20 2001-04-18 Smagskaskerende overtrækssammensætning DK1276470T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55792400A 2000-04-20 2000-04-20
PCT/US2001/012709 WO2001080826A2 (en) 2000-04-20 2001-04-18 Taste masking coating composition

Publications (1)

Publication Number Publication Date
DK1276470T3 true DK1276470T3 (da) 2007-06-18

Family

ID=24227421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01930585T DK1276470T3 (da) 2000-04-20 2001-04-18 Smagskaskerende overtrækssammensætning

Country Status (9)

Country Link
US (1) US6663893B2 (US06663893-20031216-C00001.png)
EP (1) EP1276470B1 (US06663893-20031216-C00001.png)
AT (1) ATE361061T1 (US06663893-20031216-C00001.png)
AU (1) AU2001257107A1 (US06663893-20031216-C00001.png)
DE (1) DE60128215T2 (US06663893-20031216-C00001.png)
DK (1) DK1276470T3 (US06663893-20031216-C00001.png)
ES (1) ES2284643T3 (US06663893-20031216-C00001.png)
PT (1) PT1276470E (US06663893-20031216-C00001.png)
WO (1) WO2001080826A2 (US06663893-20031216-C00001.png)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
US20060134054A1 (en) * 2003-12-19 2006-06-22 Council Of Scientific And Industrial Research Polymer composition for pH dependent dissolution behavior and process for preparation thereof
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
ATE378042T1 (de) * 2004-04-12 2007-11-15 Pfizer Prod Inc Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
DE602005002728T2 (de) * 2005-02-18 2008-07-24 The Procter & Gamble Company, Cincinnati Coffein enthaltendes Konfekt
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
FR2891147B1 (fr) * 2005-09-28 2007-12-07 Ethypharm Sa Comprimes orodispersibles de principes actifs amers
US20080138397A1 (en) * 2006-10-24 2008-06-12 Aradigm Corporation Processes for taste-masking of inhaled formulations
WO2008065504A1 (en) 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
EP2240018B1 (en) 2008-01-04 2016-05-25 Schabar Research Associates LLC Composition comprising an analgesic and an antihistamine
PL2379111T3 (pl) 2008-12-12 2013-08-30 Paladin Labs Inc Preparaty leków narkotycznych o obniżonym potencjale uzależniającym
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
CN102753196A (zh) * 2009-12-10 2012-10-24 莫诺索尔克斯有限公司 口服薄膜条内掩味的pH敏感性化合物
EP2621479B1 (de) * 2010-09-27 2017-11-29 Basf Se Protektive überzüge für saure wirkstoffe
EP3062778A4 (en) * 2013-10-31 2017-07-19 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
WO2015065547A1 (en) * 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
US9642811B2 (en) * 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
WO2017007515A1 (en) * 2015-07-09 2017-01-12 Universal Nutrients, Llc Pharmaceutical compositions
CN106389339B (zh) * 2015-08-12 2020-08-04 北京科信必成医药科技发展有限公司 一种阿司匹林无水吞服掩味颗粒及其制备方法
CN105935445B (zh) * 2016-03-28 2019-02-01 赤峰赛林泰药业有限公司 含2-(-4-异丁基苯基)丙酸右旋物的药物组合物及其制备方法
US11324707B2 (en) 2019-05-07 2022-05-10 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
IL299845A (en) 2020-07-15 2023-03-01 Schabar Res Associates Llc Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531418A (en) 1965-08-18 1970-09-29 Ncr Co En masse encapsulation process
US3453360A (en) 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
AT270071B (de) 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US3935326A (en) 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US4060598A (en) 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3577512A (en) 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3576760A (en) * 1969-06-13 1971-04-27 Nat Patent Dev Corp Water soluble entrapping
US3629392A (en) 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
DE2031871C3 (de) 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3821422A (en) 1971-03-04 1974-06-28 Merck & Co Inc Devil's food cake and other alkaline bakery goods
US3909444A (en) 1971-08-05 1975-09-30 Ncr Co Microcapsule
US4016254A (en) 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
BE791458A (fr) 1972-07-31 1973-05-16 Merck & Co Inc Produit microencapsule
DE2340060A1 (de) 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
US4112215A (en) 1975-03-20 1978-09-05 Rohm Gmbh Copolymeric resin binder powders
DE3049179A1 (de) 1975-03-20 1982-07-29 Röhm GmbH, 6100 Darmstadt Bindemittel fuer arzneimittelueberzuege.
JPS5840529B2 (ja) 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
SE418247B (sv) 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
CA1125698A (en) 1978-03-09 1982-06-15 Masaru Yoshida Process for preparing a polymer composition
US4330338A (en) 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
DE3000979A1 (de) 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4321253A (en) 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4587118A (en) 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
IT1168014B (it) 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3208791A1 (de) 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
US4749575A (en) 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
CH658188A5 (de) 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
IT1214629B (it) 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
US4975283A (en) 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
IT1188212B (it) 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4710384A (en) 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
IT1200217B (it) 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
US4760093A (en) 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4800087A (en) 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4968508A (en) 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
KR960011236B1 (ko) 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
FR2618331B1 (fr) 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
US4851226A (en) 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
JPH0273011A (ja) 1988-07-28 1990-03-13 Warner Lambert Co 医薬投与剤型製造用のセルロースおよびアクリル系重合体の水性重合体分散体およびその投与剤型
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
US5084278A (en) 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
DE69109282T2 (de) 1990-04-11 1995-09-28 Upjohn Co Verfahren zum geschmacksabdecken von ibuprofen.
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
JP3265680B2 (ja) 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
CA2148465C (en) 1992-11-06 1999-11-02 Minenobu Okayama Oral pharmaceutical preparation releasable in the lower digestive tract
US5260069A (en) 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5639475A (en) 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5633046A (en) 1995-05-22 1997-05-27 Xerox Corporation Multiple dip coating method
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US6482823B1 (en) * 1999-07-09 2002-11-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical liquid formulations

Also Published As

Publication number Publication date
PT1276470E (pt) 2007-08-13
EP1276470A2 (en) 2003-01-22
ATE361061T1 (de) 2007-05-15
US20020197317A1 (en) 2002-12-26
DE60128215T2 (de) 2008-01-10
AU2001257107A1 (en) 2001-11-07
US6663893B2 (en) 2003-12-16
EP1276470B1 (en) 2007-05-02
WO2001080826A3 (en) 2002-03-21
ES2284643T3 (es) 2007-11-16
WO2001080826A2 (en) 2001-11-01
DE60128215D1 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
DK1276470T3 (da) Smagskaskerende overtrækssammensætning
DK1276469T3 (da) Smagsmaskerende overtrækssammensætning
EP2261200A3 (en) Modified forms of pharmacacologically active agents and uses therefor
NO20016346D0 (no) Ny formulering
ATE391496T1 (de) Geschmacksmaskierte pharmazeutische formulierungen
CA2315261A1 (en) Oral pharmaceutical extended release dosage form
CO5271674A1 (es) Particulas farmaceuticas con enmascaramiento de sabor
EP1268412B8 (en) Sulphonamido-substituted bridged bicycloalkyl derivatives
ATE329608T1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
EA200300081A1 (ru) Гидрогель-управляемая лекарственная форма
BR0013935A (pt) IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
PT1152662E (pt) Utilizacao da 3-(2,4,6-trimetilfenil)-4-neopentilcarboniloxi-5,5-tetrametileno-delta3-di-hidrofuran-2-ona no combate a mosca branca
AR036658A1 (es) Formulacion de dosificacion oral de fundicion instantanea
KR950031052A (ko) 알푸조신 히드로클로라이드의 서방성 투약형태
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
HRP20090022T3 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
ATE360428T1 (de) Analgetisches arzneimittel
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
SE0001916D0 (sv) Novel formulation
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
WO2001095916A3 (de) Anticholestatisches arzneimittel